Jane Agergaard

657 total citations
21 papers, 395 citations indexed

About

Jane Agergaard is a scholar working on Neurology, Infectious Diseases and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Jane Agergaard has authored 21 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 6 papers in Infectious Diseases and 6 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Jane Agergaard's work include Long-Term Effects of COVID-19 (14 papers), COVID-19 Clinical Research Studies (5 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Jane Agergaard is often cited by papers focused on Long-Term Effects of COVID-19 (14 papers), COVID-19 Clinical Research Studies (5 papers) and Intensive Care Unit Cognitive Disorders (5 papers). Jane Agergaard collaborates with scholars based in Denmark, Guinea-Bissau and Gambia. Jane Agergaard's co-authors include Lars Østergaard, Christian Wejse, Steffen Leth, Carsten Schade Larsen, Hatice Tankişi, Thomas Holm Pedersen, Henning Andersen, Thomas Harbo, Martin Mølhave and Jesper Damsgaard Gunst and has published in prestigious journals such as International Journal of Environmental Research and Public Health, Vaccine and Clinical Neurophysiology.

In The Last Decade

Jane Agergaard

20 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Agergaard Denmark 11 251 115 85 73 67 21 395
Anahita Jafari United States 7 308 1.2× 136 1.2× 143 1.7× 43 0.6× 93 1.4× 13 435
Elizabeth Zapata Colombia 7 202 0.8× 149 1.3× 52 0.6× 41 0.6× 31 0.5× 8 351
Rosa María Sánchez Pérez Spain 7 417 1.7× 226 2.0× 212 2.5× 77 1.1× 101 1.5× 20 574
Taeyoung Choi United States 7 322 1.3× 307 2.7× 109 1.3× 35 0.5× 94 1.4× 12 611
Guoqiang Cao China 7 207 0.8× 122 1.1× 115 1.4× 39 0.5× 124 1.9× 25 400
Tahmina Nasserie United States 5 369 1.5× 149 1.3× 207 2.4× 78 1.1× 101 1.5× 6 479
Jens Detollenaere Belgium 4 310 1.2× 144 1.3× 124 1.5× 58 0.8× 73 1.1× 10 391
Paul Balfanz Germany 9 387 1.5× 280 2.4× 164 1.9× 40 0.5× 119 1.8× 16 591
Mari Terada Japan 10 247 1.0× 252 2.2× 106 1.2× 37 0.5× 37 0.6× 33 423
Célia Primus-de Jong United States 3 312 1.2× 144 1.3× 123 1.4× 58 0.8× 75 1.1× 11 379

Countries citing papers authored by Jane Agergaard

Since Specialization
Citations

This map shows the geographic impact of Jane Agergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Agergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Agergaard more than expected).

Fields of papers citing papers by Jane Agergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Agergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Agergaard. The network helps show where Jane Agergaard may publish in the future.

Co-authorship network of co-authors of Jane Agergaard

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Agergaard. A scholar is included among the top collaborators of Jane Agergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Agergaard. Jane Agergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jørgensen, Sofie E., Cagla Cömert, Berit Schiøttz‐Christensen, et al.. (2025). Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID. Journal of Medical Virology. 97(3). e70275–e70275.
2.
Jørgensen, Sofie E., Morten Kelder Skouboe, Jane Agergaard, et al.. (2023). Examination of autoantibodies to type I interferon in patients suffering from long COVID. Journal of Medical Virology. 95(9). e29089–e29089. 5 indexed citations
3.
Agergaard, Jane, et al.. (2023). Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants. International Journal of Infectious Diseases. 137. 126–133. 20 indexed citations
4.
Wejse, Christian, et al.. (2023). Effect of Vitamin D in Long COVID Patients. International Journal of Environmental Research and Public Health. 20(22). 7058–7058. 9 indexed citations
5.
Mogensen, Trine H., Jane Agergaard, Berit Schiøttz‐Christensen, et al.. (2022). High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. The Lancet Regional Health - Europe. 24. 100539–100539. 29 indexed citations
6.
Agergaard, Jane, Steffen Leth, Esben Søvsø Szocska Hansen, et al.. (2022). Cardiac Performance and Cardiopulmonary Fitness After Infection With SARS-CoV-2. Frontiers in Cardiovascular Medicine. 9. 871603–871603. 11 indexed citations
7.
Agergaard, Jane, et al.. (2022). Characteristics of a Danish Post-COVID Cohort Referred for Examination due to Persistent Symptoms Six Months after Mild Acute COVID-19. Journal of Clinical Medicine. 11(24). 7338–7338. 7 indexed citations
8.
Agergaard, Jane & Hatice Tankişi. (2022). TH-243. Post COVID-19 myopathy. Clinical Neurophysiology. 141. S163–S163. 1 indexed citations
9.
Hejbøl, Eva Kildall, Thomas Harbo, Jane Agergaard, et al.. (2022). Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology. European Journal of Neurology. 29(9). 2832–2841. 71 indexed citations
10.
Fjældstad, Alexander Wieck, et al.. (2022). Long‐Term COVID‐19 Smell and Taste Disorders Differ Significantly from Other Post‐Infectious Cases. The Laryngoscope. 133(1). 169–174. 12 indexed citations
11.
Leth, Steffen, Jesper Damsgaard Gunst, Victor Næstholt Dahl, et al.. (2021). Persistent symptoms in hospitalized patients recovering from COVID-19 in Denmark. Open Forum Infectious Diseases. 3 indexed citations
12.
Mølhave, Martin, Jane Agergaard, & Christian Wejse. (2021). Clinical Management of COVID-19 Patients – An Update. Seminars in Nuclear Medicine. 52(1). 4–10. 33 indexed citations
13.
Agergaard, Jane, Steffen Leth, Thomas Holm Pedersen, et al.. (2021). Myopathic changes in patients with long-term fatigue after COVID-19. Clinical Neurophysiology. 132(8). 1974–1981. 58 indexed citations
14.
Leth, Steffen, Jesper Damsgaard Gunst, Victor Næstholt Dahl, et al.. (2021). Persistent Symptoms in Patients Recovering From COVID-19 in Denmark. Open Forum Infectious Diseases. 8(4). ofab042–ofab042. 46 indexed citations
15.
Mølhave, Martin, Steffen Leth, Jesper Damsgaard Gunst, et al.. (2021). Long-Term Symptoms among Hospitalized COVID-19 Patients 48 Weeks after Discharge—A Prospective Cohort Study. Journal of Clinical Medicine. 10(22). 5298–5298. 9 indexed citations
16.
Agergaard, Jane & Carsten Schade Larsen. (2015). Acute acalculous cholecystitis in a patient with primary Epstein-Barr virus infection: a case report and literature review. International Journal of Infectious Diseases. 35. 67–72. 35 indexed citations
17.
Thorsen, Kasper, et al.. (2013). Leukocyte transcript alterations in West-African girls following a booster vaccination with diphtheria-tetanus-pertussis vaccine. Scandinavian Journal of Clinical and Laboratory Investigation. 73(4). 349–354. 2 indexed citations
18.
Fisker, Ane Bærent, Peter Aaby, C Balé, et al.. (2012). Does the effect of vitamin A supplements depend on vaccination status? An observational study from Guinea-Bissau. BMJ Open. 2(1). e000448–e000448. 17 indexed citations
19.
Agergaard, Jane, et al.. (2010). Serological evidence for Chlamydia pneumoniae infection following diphtheria-tetanus-pertussis booster vaccination. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anahita Jafari Breakdown of academic impact, for papers by Elizabeth Zapata Breakdown of academic impact, for papers by Rosa María Sánchez Pérez Breakdown of academic impact, for papers by Taeyoung Choi Breakdown of academic impact, for papers by Guoqiang Cao Breakdown of academic impact, for papers by Tahmina Nasserie Breakdown of academic impact, for papers by Jens Detollenaere Breakdown of academic impact, for papers by Paul Balfanz Breakdown of academic impact, for papers by Mari Terada Breakdown of academic impact, for papers by Célia Primus-de Jong
Rankless by CCL
2026